Tempus ECG-AF vs DeepTek CXR Analyzer
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify elderly patients (65+) at elevated risk of developing new-onset atrial fibrillation within the next year, based on their 12-lead ECGs. This tool is ideal for integrating into cardiology, geriatrics, or internal medicine practices to support earlier intervention and follow-up for AF risk management.
View Tempus ECG-AF →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if you aim to enhance the efficiency and accuracy of your radiology department's chest X-ray interpretation workflow. This AI-powered solution is best suited for assisting radiologists by automatically detecting and highlighting a wide range of lung, pleural, and cardiac pathologies, thereby reducing workload and accelerating diagnostic turnaround times.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Contact vendor | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer explicitly details seamless DICOM-based PACS integration and quantifies benefits like reducing radiologist workload by 30-50% and boosting productivity by 2x-3x, indicating a strong focus on user efficiency and workflow optimization. Tempus ECG-AF's description of integration is more general, lacking specific workflow enhancements or quantified user benefits.
Clinical Value
DeepTek CXR AnalyzerDeepTek CXR Analyzer offers a broader clinical impact by detecting 28 findings across lung, pleural, and cardiac pathologies, directly assisting radiologists in improving diagnostic accuracy and efficiency. While Tempus ECG-AF provides valuable predictive risk for AF, its scope is narrower compared to the comprehensive diagnostic assistance offered by Tool B.
Pricing & Value
Tempus ECG-AFTempus ECG-AF provides clear pricing transparency by detailing CMS reimbursement availability, including specific CPT codes (0764T and 0765T) and a Medicare rate of $128.90. This concrete financial information allows healthcare providers to better assess the economic value and potential return on investment. DeepTek CXR Analyzer offers a 'pay-per-use' model but lacks specific financial details.
Enterprise Readiness
DeepTek CXR AnalyzerBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs. However, DeepTek CXR Analyzer stands out by explicitly offering both cloud and on-premise deployment options, coupled with seamless DICOM-based PACS integration for both environments. This flexibility demonstrates superior adaptability to diverse enterprise IT infrastructures and security preferences.
Innovation
Tempus ECG-AFTempus ECG-AF demonstrates a higher degree of innovation through its predictive capability, identifying patients at risk of developing atrial fibrillation within the next 12 months from a standard ECG. This proactive, forward-looking application of AI for risk stratification is a more novel approach compared to DeepTek CXR Analyzer's comprehensive but primarily diagnostic detection capabilities.
Support & Docs
DeepTek CXR AnalyzerDeepTek provides more explicit details about its support infrastructure, including a dedicated customer support email, a job description outlining technical support responsibilities (phone, email, remote assistance, ticketing systems, training), and a 'Resources Hub.' While Tempus also offers support channels and a resource center, DeepTek's information suggests a more structured and comprehensive support framework.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | DeepTek CXR Analyzer |
|---|---|---|
| Name | Tempus ECG-AF | DeepTek CXR Analyzer |
| Description | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | FDA-cleared AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, significantly improving workflow efficiency and diagnostic accuracy. |
| Company | Tempus AI, Inc. | DeepTek Medical Imaging Pvt |
| Categories | Cardiology AI | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Geriatrics, Internal Medicine | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and DeepTek CXR Analyzer.